• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Neuberger Berman High Yield Strategies

Neuberger Berman High Yield Strategies

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. 3D4Medical Announces the Appointment of Top Academics to Its Academic Review Board

    3D4Medical Announces the Appointment of Top Academics to Its Academic Review Board

  2. Evotec AG: 'LAB282' Awarded First Projects

    Evotec AG: 'LAB282' Awarded First Projects

  3. FlowAid Receives FDA US Market Clearance for the FA100 SCCD

    FlowAid Receives FDA US Market Clearance for the FA100 SCCD

  4. Owlstone Medical Commences 1,400 Patient Clinical Trial for Early Detection of Colorectal Cancer

    Owlstone Medical Commences 1,400 Patient Clinical Trial for Early Detection of Colorectal Cancer

  5. Cyprotex, an Evotec Company, Expands into New UK Facility at Alderley Park

    Cyprotex, an Evotec Company, Expands into New UK Facility at Alderley Park

  6. Japan Equity CEFs Win the First Quarter

    These closed-end funds were unstoppable in early 2015; plus, did the first IPO of 2015 usher in a new era for CEF shareholders?

  7. Observations about Neuberger Berman Closed-End Fund Tender Offers

    Dan Plettner invests and receives income for securities research, including “buy-side” research. Dan licenses his own real time trading data to Covestor Ltd. (“Covestor”), frequently including positions discussed in his Morningstar Contributions. Covestor is a Registered Investment Advisor that ...

©2017 Morningstar Advisor. All right reserved.